Difebarbamate
- Level
- Commodity
- Parent
- 51361900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51361913This classification denotes a sedative and hypnotic with the molecular formula C28H42N4O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7EE4K616KK, chemically known as 1,3-bis(3-butoxy-2-hydroxypropyl)-5-ethyl-5-phenylbarbituric acid dicarbamate ester but generally known as difebarbamate, which bears US NIH Compound Identifier 71880. European Medicines Agency schedules Difebarbamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07116MIG. The term DIFEBARBAMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). DIFEBARBAMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule difebarbamate under HS 29335400 and SITC kg. As of Q4 2014, DIFEBARBAMATE remains the US FDA Preferred Term for this commodity. Difebarbamate bears US NLM identifiers UMLS ID C0057977 and NCI Concept Code C77252. SMILES: O=C1N(C(=O)N(C(=O)C1(CC)C1CCCCC1)CC(OC(=O)N)COCCCC)CC(OC(=O)N)COCCCC.
Same parent
Under 51361900 · 41Activities that produce or sell this
KBLI · 8Inherited from family 51360000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.